Category Specific RSS

John Melki

Genetic Signatures halts development of US respiratory product due to competition

Global molecular diagnostics company Genetic Signatures (ASX: GSS) has decided to halt the development of its EasyScreen Essentials Respiratory Detection…

1 year ago

Genetic Signatures receives TGA nod for updated respiratory kit in time for influenza season

Flu season is around the corner, typically affecting us between May and September. Just in time for that, Australian global…

1 year ago

Genetic Signatures lodges FDA application for rapid test kit to detect intestinal parasites

Gastrointestinal (GI) parasites are a pressing public health issue, affecting both humans and animals. Unfortunately, these diseases often go undiagnosed…

2 years ago

Genetic Signatures’ testing kits approved in EU to address worrying STI numbers

Every day there are more than 1 million sexually transmitted infections (STI) contracted, but biotech company Genetic Signatures (ASX: GSS)…

4 years ago

TGA approves coronavirus testing kit, Genetic Signatures to flatten curve

Biotech company Genetic Signatures (ASX: GSS) is poised to play a major role in flattening the curve of coronavirus cases…

5 years ago